Amphastar Pharmaceuticals Quick Ratio 2012-2024 | AMPH

Historical quick ratio values for Amphastar Pharmaceuticals (AMPH) over the last 10 years.
Amphastar Pharmaceuticals Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2024-09-30 $0.42B $0.16B 2.61
2024-06-30 $0.36B $0.14B 2.63
2024-03-31 $0.44B $0.26B 1.72
2023-12-31 $0.38B $0.23B 1.70
2023-09-30 $0.43B $0.26B 1.68
2023-06-30 $0.28B $0.25B 1.11
2023-03-31 $0.30B $0.11B 2.88
2022-12-31 $0.28B $0.10B 2.90
2022-09-30 $0.28B $0.10B 2.75
2022-06-30 $0.28B $0.10B 2.69
2022-03-31 $0.27B $0.11B 2.35
2021-12-31 $0.23B $0.10B 2.17
2021-09-30 $0.20B $0.10B 2.08
2021-06-30 $0.21B $0.13B 1.71
2021-03-31 $0.20B $0.13B 1.60
2020-12-31 $0.18B $0.11B 1.63
2020-09-30 $0.17B $0.10B 1.73
2020-06-30 $0.16B $0.09B 1.74
2020-03-31 $0.14B $0.08B 1.67
2019-12-31 $0.15B $0.09B 1.61
2019-09-30 $0.16B $0.09B 1.84
2019-06-30 $0.19B $0.10B 1.83
2019-03-31 $0.15B $0.11B 1.35
2018-12-31 $0.15B $0.11B 1.41
2018-09-30 $0.13B $0.10B 1.34
2018-06-30 $0.11B $0.09B 1.24
2018-03-31 $0.11B $0.07B 1.53
2017-12-31 $0.12B $0.07B 1.85
2017-09-30 $0.11B $0.06B 1.86
2017-06-30 $0.12B $0.06B 1.87
2017-03-31 $0.11B $0.07B 1.56
2016-12-31 $0.10B $0.06B 1.72
2016-09-30 $0.10B $0.06B 1.64
2016-06-30 $0.09B $0.07B 1.42
2016-03-31 $0.09B $0.07B 1.41
2015-12-31 $0.11B $0.06B 1.76
2015-09-30 $0.13B $0.07B 1.79
2015-06-30 $0.12B $0.07B 1.78
2015-03-31 $0.12B $0.07B 1.63
2014-12-31 $0.12B $0.06B 1.85
2014-09-30 $0.13B $0.06B 2.02
2014-06-30 $0.11B $0.06B 1.92
2014-03-31 $0.10B $0.07B 1.35
2013-12-31 $0.10B $0.07B 1.58
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.11B $0.06B 1.90
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2012-03-31 $0.00B 0.00
2011-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.097B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00